FDA Outlines Data Required for Modifying COVID-19 Vaccines Against Viral Variants
April 1, 2021
Three guidances released by the FDA last month detail the agency’s requirements for trials that deal with COVID-19 variants, including those for vaccines, monoclonal antibodies and treatments.
